1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Swapna, G.V.T.
Ciccosanti, C.L.
Belote, R.
Hamilton, K.
Acton, T.
Huang, Y.
Xiao, R.
Everett, J.
Montelione, G.T.
Northeast Structural Genomics Consortium (NESG)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
NMR solution structure of Lamin-B1 protein from Homo sapiens: Northeast Structural Genomics Consortium target, HR5546A (439-549)
10.2210/pdb2kpw/pdb
pdb_00002kpw
13672.312
Lamin-B1
sequence database residues 439-549
1
man
polymer
no
no
MGHHHHHHSHMTGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTA
SPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTT
MGHHHHHHSHMTGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTA
SPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTT
A
HR5546A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
LMN2, LMNB, LMNB1
9606
Homo sapiens
469008
Escherichia coli
BL21(DE3)+Magic
pET 14-15C
Vector
Northeast Structural Genomics Consortium
NESG
PSI, Protein Structure Initiative
pdbx_database_status
pdbx_nmr_representative
pdbx_nmr_sample_details
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
database_2
pdbx_nmr_exptl_sample
pdbx_nmr_sample_details
struct
pdbx_database_status
repository
Initial release
Version format compliance
Data collection
Database references
Derived calculations
Experimental preparation
Other
Database references
Experimental preparation
Structure summary
Other
1
0
2009-11-10
1
1
2011-07-13
1
2
2020-02-26
1
3
2021-08-18
1
4
2023-06-14
_pdbx_database_status.status_code_cs
_pdbx_nmr_representative.selection_criteria
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct.pdbx_model_details
_pdbx_database_status.status_code_nmr_data
Y
BMRB
Y
RCSB
2009-10-21
REL
REL
REL
REL
THE STRUCTURE WAS DETERMINED USING TRIPLE RESONANCE SPECTROSCOPY. DATA FOR THE BACKBONE ASSIGNMENTS WAS ACQUIRED USING GFT NMR EXPERIMENTS. AUTOMATED RESONANCE ASSIGNMENTS WERE MADE USING AUTOASSIGN AND PATTERN-PICKER ALGORITHMS DEVELOPED FOR AUTOMATED ASSIGNMENTS OF GFT DATA. SIDE CHAIN ASSIGNMENTS WERE COMPLETED MANUALLY. AUTOMATED NOESY ASSIGNMENTS WERE MADE USING AUTOSTRUCTURE AND STRUCTURE SOLUTION WAS DETERMINED USING CYANA-2.1. 100 STRUCTURES WERE CALCULATED AND 20 BEST CONFORMERS WERE THEN REFINED IN A SHELL OF WATER USING CNS. INITIAL DIHEDRAL ANGLE CONSTRIANTS WERE OBTAINED FROM TALOS. COMPLETENESS OF THE ASSIGNMENTS INCLUDING THE N-TERMINAL 6XHIS TAG WERE BACKBONE:99% SIDECHAIN: 96%. THE ASSIGNMENTS WERE VALIDATED USING AVS SOFTWARE.
structures with the lowest energy
100
20
0.0
2D 1H-15N HSQC
2D 1H-13C HSQC
3D HNCACB
3D CBCA(CO)NH
3D HBHA(CO)NH
3D HNCO
3D HNHA
3D HCCH-TOCSY
3D 1H-15N NOESY
3D 1H-13C NOESY
2D HNOE
1.129
mM
[U-100% 13C; U-100% 15N]
20mM NH4OAc, 5mM CACL2, 200mM NACL
4.5
AMBIENT
298
K
FINAL STRUCTURE QUALITY FACTORS DETERMINED USING PSVS SOFTWARE: ORDERED RESIDUES ARE DEFINED AS:15A-32A,34A-37A,42A-47A,53A-72A,75A-79A,85A-91A,101A-106A, 110A-116A.(A) RMSD(ORDERED RESIDUES):BACKBONE ATOMS: 0.7A; ALL ATOMS: 1.0A.(B) RAMACHANDRAN STATISTICS FOR ALL ORDERED RESIDUES: MOST FAVOURED REGIONS: 83.1% ADDITIONALLY ALLOWED REGIONS:16.9% (C) PROCHECK SCORES FOR ALL ORDERED RESIDUES (RAW/Z): PHI-PSI -0.76/-2.68, ALL: -0.42/-2.48 (D) MOLPROBITY CLASH SCORE (RAW/Z): 20.38/-1.97. (E) RPF SCORES FOR GOODNESS OF FIT TO NOESY DATA: RECALL:0.962 PRECISION: 0.919 F-MEASURE: 0.94 DP-SCORE 0.794.
simulated annealing
1
lowest energy
1.129 MM [U-100% 13C; U-100% 15N] LAMIN-B1 PROTEIN, 90% H2O/10% D2O
1
90% H2O/10% D2O
solution
BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ
refinement
CNS
2.0.6
Zimmerman, Moseley, Kulikowski and Montelione
chemical shift assignment
AutoAssign
2.1
Moseley and Montelione
chemical shift assignment
AVS
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
2008
Goddard
peak picking
Sparky
2.3
Huang, Tejero, Powers and Montelione
structure solution
AutoStructure
2.2.1
Guntert, Mumenthaler and Wuthrich
geometry optimization
CYANA
2.1
Bruker Biospin
collection
TopSpin
2.1
Varian
collection
VnmrJ
2.1
Goddard
data analysis
Sparky
2.3
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
2.1
600
Varian
INOVA
800
Bruker
AVANCE
MET
1
n
1
MET
1
A
GLY
2
n
2
GLY
2
A
HIS
3
n
3
HIS
3
A
HIS
4
n
4
HIS
4
A
HIS
5
n
5
HIS
5
A
HIS
6
n
6
HIS
6
A
HIS
7
n
7
HIS
7
A
HIS
8
n
8
HIS
8
A
SER
9
n
9
SER
9
A
HIS
10
n
10
HIS
10
A
MET
11
n
11
MET
11
A
THR
12
n
12
THR
12
A
GLY
13
n
13
GLY
13
A
ASN
14
n
14
ASN
14
A
VAL
15
n
15
VAL
15
A
CYS
16
n
16
CYS
16
A
ILE
17
n
17
ILE
17
A
GLU
18
n
18
GLU
18
A
GLU
19
n
19
GLU
19
A
ILE
20
n
20
ILE
20
A
ASP
21
n
21
ASP
21
A
VAL
22
n
22
VAL
22
A
ASP
23
n
23
ASP
23
A
GLY
24
n
24
GLY
24
A
LYS
25
n
25
LYS
25
A
PHE
26
n
26
PHE
26
A
ILE
27
n
27
ILE
27
A
ARG
28
n
28
ARG
28
A
LEU
29
n
29
LEU
29
A
LYS
30
n
30
LYS
30
A
ASN
31
n
31
ASN
31
A
THR
32
n
32
THR
32
A
SER
33
n
33
SER
33
A
GLU
34
n
34
GLU
34
A
GLN
35
n
35
GLN
35
A
ASP
36
n
36
ASP
36
A
GLN
37
n
37
GLN
37
A
PRO
38
n
38
PRO
38
A
MET
39
n
39
MET
39
A
GLY
40
n
40
GLY
40
A
GLY
41
n
41
GLY
41
A
TRP
42
n
42
TRP
42
A
GLU
43
n
43
GLU
43
A
MET
44
n
44
MET
44
A
ILE
45
n
45
ILE
45
A
ARG
46
n
46
ARG
46
A
LYS
47
n
47
LYS
47
A
ILE
48
n
48
ILE
48
A
GLY
49
n
49
GLY
49
A
ASP
50
n
50
ASP
50
A
THR
51
n
51
THR
51
A
SER
52
n
52
SER
52
A
VAL
53
n
53
VAL
53
A
SER
54
n
54
SER
54
A
TYR
55
n
55
TYR
55
A
LYS
56
n
56
LYS
56
A
TYR
57
n
57
TYR
57
A
THR
58
n
58
THR
58
A
SER
59
n
59
SER
59
A
ARG
60
n
60
ARG
60
A
TYR
61
n
61
TYR
61
A
VAL
62
n
62
VAL
62
A
LEU
63
n
63
LEU
63
A
LYS
64
n
64
LYS
64
A
ALA
65
n
65
ALA
65
A
GLY
66
n
66
GLY
66
A
GLN
67
n
67
GLN
67
A
THR
68
n
68
THR
68
A
VAL
69
n
69
VAL
69
A
THR
70
n
70
THR
70
A
ILE
71
n
71
ILE
71
A
TRP
72
n
72
TRP
72
A
ALA
73
n
73
ALA
73
A
ALA
74
n
74
ALA
74
A
ASN
75
n
75
ASN
75
A
ALA
76
n
76
ALA
76
A
GLY
77
n
77
GLY
77
A
VAL
78
n
78
VAL
78
A
THR
79
n
79
THR
79
A
ALA
80
n
80
ALA
80
A
SER
81
n
81
SER
81
A
PRO
82
n
82
PRO
82
A
PRO
83
n
83
PRO
83
A
THR
84
n
84
THR
84
A
ASP
85
n
85
ASP
85
A
LEU
86
n
86
LEU
86
A
ILE
87
n
87
ILE
87
A
TRP
88
n
88
TRP
88
A
LYS
89
n
89
LYS
89
A
ASN
90
n
90
ASN
90
A
GLN
91
n
91
GLN
91
A
ASN
92
n
92
ASN
92
A
SER
93
n
93
SER
93
A
TRP
94
n
94
TRP
94
A
GLY
95
n
95
GLY
95
A
THR
96
n
96
THR
96
A
GLY
97
n
97
GLY
97
A
GLU
98
n
98
GLU
98
A
ASP
99
n
99
ASP
99
A
VAL
100
n
100
VAL
100
A
LYS
101
n
101
LYS
101
A
VAL
102
n
102
VAL
102
A
ILE
103
n
103
ILE
103
A
LEU
104
n
104
LEU
104
A
LYS
105
n
105
LYS
105
A
ASN
106
n
106
ASN
106
A
SER
107
n
107
SER
107
A
GLN
108
n
108
GLN
108
A
GLY
109
n
109
GLY
109
A
GLU
110
n
110
GLU
110
A
GLU
111
n
111
GLU
111
A
VAL
112
n
112
VAL
112
A
ALA
113
n
113
ALA
113
A
GLN
114
n
114
GLN
114
A
ARG
115
n
115
ARG
115
A
SER
116
n
116
SER
116
A
THR
117
n
117
THR
117
A
VAL
118
n
118
VAL
118
A
PHE
119
n
119
PHE
119
A
LYS
120
n
120
LYS
120
A
THR
121
n
121
THR
121
A
THR
122
n
122
THR
122
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
16
A
N
CYS
16
A
O
LYS
30
A
O
LYS
30
A
N
ILE
27
A
N
ILE
27
A
O
ILE
71
A
O
ILE
71
A
N
THR
70
A
N
THR
70
A
O
LEU
86
A
O
LEU
86
A
N
GLN
37
A
N
GLN
37
A
O
LEU
63
A
O
LEU
63
A
O
TYR
55
A
O
TYR
55
A
N
MET
44
A
N
MET
44
A
N
LYS
47
A
N
LYS
47
A
O
LYS
101
A
O
LYS
101
A
N
VAL
102
A
N
VAL
102
A
O
ARG
115
A
O
ARG
115
12
A
A
HH11
HZ3
ARG
TRP
46
88
1.35
1
A
A
PRO
PRO
82
83
38.83
7
A
A
PRO
PRO
82
83
36.16
9
A
A
PRO
PRO
82
83
38.02
17
A
A
PRO
PRO
82
83
44.60
1
A
HIS
4
-171.11
148.50
1
A
HIS
7
-166.43
116.88
1
A
THR
32
-109.36
40.84
1
A
ILE
48
-164.51
-53.80
1
A
ASP
50
69.07
-69.24
1
A
ALA
74
60.66
-73.37
1
A
ALA
76
-133.03
-39.94
1
A
SER
81
67.25
71.45
1
A
PRO
83
13.41
60.79
1
A
THR
84
153.68
-52.93
1
A
TRP
88
-69.14
91.04
1
A
THR
96
-79.83
28.34
1
A
ASP
99
-52.63
101.63
1
A
PHE
119
-64.19
91.65
2
A
HIS
8
-57.52
90.68
2
A
SER
9
-126.72
-169.68
2
A
ASN
14
-68.16
81.00
2
A
ILE
48
-150.22
21.48
2
A
SER
52
-145.37
33.03
2
A
ASN
75
-93.71
43.18
2
A
ASP
99
-67.92
89.18
3
A
SER
81
59.83
81.36
3
A
THR
84
-171.02
-38.20
3
A
THR
96
176.46
-27.27
3
A
ASP
99
-64.52
99.32
3
A
ALA
113
-176.67
133.70
4
A
ASN
14
-76.84
47.69
4
A
GLU
18
-90.56
-69.25
4
A
LYS
30
-162.66
119.90
4
A
ILE
48
-135.99
-41.43
4
A
ASP
50
72.47
-36.51
4
A
THR
84
-154.96
-56.36
4
A
THR
96
-157.35
26.25
5
A
THR
12
-91.38
32.19
5
A
PRO
38
-74.80
29.90
5
A
MET
39
64.94
-71.18
5
A
ASP
50
76.46
-58.75
5
A
PRO
82
-48.79
170.84
5
A
PRO
83
-16.82
-80.51
5
A
THR
84
-78.62
-83.63
5
A
TRP
88
-69.46
77.90
5
A
LYS
89
-75.88
27.82
6
A
HIS
3
-144.66
39.70
6
A
HIS
7
-66.00
99.43
6
A
MET
11
61.58
108.88
6
A
THR
12
-94.26
36.51
6
A
MET
39
-52.45
-72.26
6
A
TYR
55
-160.47
114.21
6
A
SER
59
-85.89
33.93
6
A
VAL
69
-57.96
106.66
6
A
THR
79
-51.10
104.92
6
A
PRO
82
-55.91
178.60
6
A
THR
84
176.71
-170.94
6
A
ASP
85
-57.40
108.10
6
A
LEU
86
-51.44
109.22
6
A
THR
96
-130.56
-39.09
6
A
ASN
106
-114.80
-167.40
6
A
PHE
119
28.56
75.98
7
A
HIS
6
-65.27
93.71
7
A
LYS
25
-95.57
-63.39
7
A
MET
39
-79.12
-71.01
7
A
ILE
48
-171.20
-35.70
7
A
SER
59
-73.41
23.72
7
A
ALA
74
61.30
-69.18
7
A
ASN
75
-72.86
36.17
7
A
THR
79
-67.84
94.02
7
A
ALA
80
51.64
-86.11
7
A
SER
81
-170.46
110.52
7
A
PRO
82
-46.21
160.61
7
A
PRO
83
9.03
64.50
7
A
THR
84
147.78
-67.59
7
A
THR
96
-167.52
-63.25
7
A
THR
121
66.40
98.37
8
A
GLU
34
-85.73
43.12
8
A
TYR
55
-163.57
117.99
8
A
ALA
80
-89.87
42.41
8
A
PRO
82
-44.12
163.84
8
A
PRO
83
-11.02
-80.75
8
A
THR
84
-106.37
-79.39
8
A
TRP
88
-64.91
77.96
8
A
VAL
100
30.73
88.57
8
A
ARG
115
-175.60
147.71
8
A
THR
121
57.85
102.33
9
A
MET
39
64.17
-73.27
9
A
ALA
74
56.51
-72.82
9
A
ALA
76
-154.47
9.02
9
A
SER
81
65.17
104.17
9
A
PRO
82
-45.96
169.43
9
A
PRO
83
10.76
65.45
9
A
THR
84
144.74
-59.65
9
A
ASP
85
-110.76
-168.62
9
A
ASP
99
-57.91
89.86
9
A
THR
117
-61.71
94.79
9
A
VAL
118
-68.37
86.79
9
A
PHE
119
-78.38
26.00
10
A
HIS
10
-151.44
83.17
10
A
GLU
19
173.82
152.51
10
A
MET
39
-66.28
-85.59
10
A
ILE
48
-169.74
-60.28
10
A
ASP
50
67.45
-75.75
10
A
ASN
75
-93.49
35.52
10
A
SER
93
-179.09
-178.44
10
A
TRP
94
-142.22
-82.64
10
A
SER
107
47.71
-77.52
10
A
VAL
112
-98.91
-68.07
11
A
SER
9
-178.30
112.36
11
A
GLU
18
-81.54
-77.02
11
A
PRO
38
-73.46
21.31
11
A
MET
39
63.50
-78.84
11
A
ASP
50
73.68
-56.25
11
A
ARG
60
-140.37
17.68
11
A
ASN
75
-91.08
41.57
11
A
PRO
82
-54.33
-178.34
11
A
THR
84
-158.13
-60.68
11
A
ASP
85
-122.10
-168.87
11
A
ASN
92
-109.83
-169.52
11
A
SER
107
59.92
-77.52
11
A
GLN
108
-80.93
-71.91
12
A
HIS
4
-66.75
91.78
12
A
THR
12
-73.90
-74.35
12
A
PRO
38
-77.95
48.07
12
A
MET
39
67.23
-69.40
12
A
ILE
48
-166.10
-46.48
12
A
ALA
65
-59.76
107.24
12
A
SER
81
59.96
94.54
12
A
THR
84
-163.80
-48.28
12
A
SER
93
-67.41
-173.01
12
A
SER
107
-74.45
28.96
13
A
HIS
4
-172.72
107.32
13
A
ASP
23
-121.28
-53.08
13
A
ASP
36
-52.16
104.71
13
A
ILE
48
-167.78
-40.63
13
A
SER
52
-163.07
101.51
13
A
ALA
80
-62.25
79.78
13
A
SER
81
66.08
89.87
13
A
THR
84
177.01
-44.78
13
A
GLU
98
66.41
163.13
13
A
PHE
119
-61.35
98.15
14
A
HIS
6
60.64
85.56
14
A
THR
84
-174.72
-47.17
14
A
TRP
88
-66.96
93.46
14
A
SER
93
-175.21
-179.09
14
A
GLN
114
-155.65
46.88
14
A
LYS
120
-143.90
27.12
15
A
PRO
38
-58.23
107.74
15
A
ASP
50
-136.94
-43.78
15
A
PRO
83
0.29
103.57
15
A
THR
84
51.28
-67.19
15
A
ASP
85
-68.21
-178.47
15
A
ASN
92
-100.64
-137.16
15
A
TRP
94
45.39
22.24
15
A
ASP
99
-78.39
43.97
15
A
THR
121
-140.22
31.82
16
A
ILE
48
-159.17
-42.58
16
A
SER
59
-86.46
34.62
16
A
THR
96
76.73
-32.86
16
A
ASP
99
59.12
73.29
17
A
THR
12
-96.45
-157.88
17
A
ASP
23
-81.54
-70.37
17
A
ASP
36
-64.66
91.03
17
A
ASP
50
-149.75
-15.33
17
A
ALA
74
64.83
-67.14
17
A
ALA
80
-67.69
91.05
17
A
SER
81
72.84
87.09
17
A
PRO
82
-50.67
-176.17
17
A
PRO
83
14.82
47.92
17
A
THR
84
157.67
-53.36
17
A
SER
107
-67.94
8.37
17
A
VAL
112
-122.44
-64.16
17
A
VAL
118
-62.29
96.25
18
A
HIS
6
-101.86
-78.78
18
A
GLU
19
178.52
160.46
18
A
ASP
50
70.18
-4.29
18
A
ASN
75
-97.07
32.48
18
A
ALA
80
-69.91
2.65
18
A
SER
81
-169.68
86.04
18
A
TRP
88
-69.60
79.35
18
A
THR
96
-170.95
-42.69
18
A
PHE
119
-59.71
95.59
19
A
ALA
74
47.47
-82.57
19
A
ASN
75
-77.46
36.24
19
A
ALA
80
-83.00
39.01
19
A
PRO
82
-44.50
-164.08
19
A
THR
84
-67.15
-71.63
19
A
SER
93
66.60
139.28
19
A
THR
96
-151.68
-50.17
19
A
PHE
119
-79.17
21.78
19
A
LYS
120
-58.02
98.74
20
A
LYS
25
-129.81
-57.49
20
A
PRO
38
-75.94
46.51
20
A
MET
39
63.11
-79.94
20
A
THR
84
-139.08
-66.00
20
A
ASN
92
-75.24
-164.22
20
A
VAL
112
-125.08
-60.83
20
A
THR
117
-68.45
-94.37
20
A
VAL
118
176.47
130.33
20
A
THR
121
-63.46
0.09
NMR solution structure of Lamin-B1 protein from Homo sapiens: Northeast Structural Genomics Consortium MEGA target, HR5546A (439-549)
1
N
N
STRUCTURAL PROTEIN
PSI-2, NESG, HR5546A, Lamin-B1, GFT, Acetylation, Chromosomal rearrangement, Coiled coil, Intermediate filament, Leukodystrophy, Lipoprotein, Membrane, Nucleus, Phosphoprotein, Polymorphism, Prenylation, Structural Genomics, Protein Structure Initiative, Northeast Structural Genomics Consortium, STRUCTURAL PROTEIN
A
PRO
82
A
PRO
82
2
A
PRO
83
A
PRO
83
-0.92
A
PRO
82
A
PRO
82
3
A
PRO
83
A
PRO
83
-1.74
A
PRO
82
A
PRO
82
4
A
PRO
83
A
PRO
83
-0.52
A
PRO
82
A
PRO
82
5
A
PRO
83
A
PRO
83
11.18
A
PRO
82
A
PRO
82
6
A
PRO
83
A
PRO
83
6.27
A
PRO
82
A
PRO
82
8
A
PRO
83
A
PRO
83
17.11
A
PRO
82
A
PRO
82
10
A
PRO
83
A
PRO
83
3.06
A
PRO
82
A
PRO
82
11
A
PRO
83
A
PRO
83
5.27
A
PRO
82
A
PRO
82
12
A
PRO
83
A
PRO
83
-1.15
A
PRO
82
A
PRO
82
13
A
PRO
83
A
PRO
83
6.39
A
PRO
82
A
PRO
82
14
A
PRO
83
A
PRO
83
-1.62
A
PRO
82
A
PRO
82
15
A
PRO
83
A
PRO
83
25.21
A
PRO
82
A
PRO
82
16
A
PRO
83
A
PRO
83
1.44
A
PRO
82
A
PRO
82
18
A
PRO
83
A
PRO
83
2.10
A
PRO
82
A
PRO
82
19
A
PRO
83
A
PRO
83
11.03
A
PRO
82
A
PRO
82
20
A
PRO
83
A
PRO
83
-2.98
LMNB1_HUMAN
UNP
1
439
P20700
TGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQ
NSWGTGEDVKVILKNSQGEEVAQRSTVFKTT
439
549
2KPW
12
122
P20700
A
1
12
122
1
expression tag
MET
1
2KPW
A
P20700
UNP
1
1
expression tag
GLY
2
2KPW
A
P20700
UNP
2
1
expression tag
HIS
3
2KPW
A
P20700
UNP
3
1
expression tag
HIS
4
2KPW
A
P20700
UNP
4
1
expression tag
HIS
5
2KPW
A
P20700
UNP
5
1
expression tag
HIS
6
2KPW
A
P20700
UNP
6
1
expression tag
HIS
7
2KPW
A
P20700
UNP
7
1
expression tag
HIS
8
2KPW
A
P20700
UNP
8
1
expression tag
SER
9
2KPW
A
P20700
UNP
9
1
expression tag
HIS
10
2KPW
A
P20700
UNP
10
1
expression tag
MET
11
2KPW
A
P20700
UNP
11
4
2
4
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
VAL
15
A
VAL
15
A
ILE
20
A
ILE
20
A
PHE
26
A
PHE
26
A
ASN
31
A
ASN
31
A
GLN
67
A
GLN
67
A
TRP
72
A
TRP
72
A
LEU
86
A
LEU
86
A
ILE
87
A
ILE
87
A
GLN
37
A
GLN
37
A
PRO
38
A
PRO
38
A
VAL
62
A
VAL
62
A
LEU
63
A
LEU
63
A
SER
52
A
SER
52
A
LYS
56
A
LYS
56
A
GLU
43
A
GLU
43
A
LYS
47
A
LYS
47
A
LYS
101
A
LYS
101
A
LYS
105
A
LYS
105
A
GLU
111
A
GLU
111
A
SER
116
A
SER
116
1
P 1